Pharmaceutical / Drug Definition :
Thought to inhibit DNA and RNA synthesis by forming complex with DNA. Also exerts immunosuppressive activity. Cell-cycle-S-phase specific.
FDA Label Requirements and Exceptions
Doxorubicin Hydrochloride
FDA Import Information
Doxorubicin Hydrochloride
FDA Detentions
Doxorubicin Hydrochloride (Doxorubicin Hydrochloride Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Doxorubicin Hydrochloride (Doxorubicin Hydrochloride Suppliers)
- Processors Doxorubicin Hydrochloride
- Repackers Doxorubicin Hydrochloride
- Relabelers Doxorubicin Hydrochloride
- Exporters Doxorubicin Hydrochloride
- Importers Doxorubicin Hydrochloride
For more information about Doxorubicin Hydrochloride, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
